Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3010657	s-t3-vdi	— (—)	104	137	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of the thyroid gland

9.12

32.37

1.5

1.1

—

Hypothyroidism, other/unspecified

9.10

31.17

1.6

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

8.04

29.83

1.6

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

6.76

21.12

1.4

1.1

—

Hypothyroidism, strict autoimmune

8.04

20.16

1.5

1.0

—

Endocrine, nutritional and metabolic diseases

10.13

15.72

2.0

1.0

—

Autoimmune diseases

5.36

15.09

1.7

1.1

—

Benzodiazepine use

4.51

14.83

1.5

1.2

—

Used for control exclusion in common control thyroid runs

6.14

14.74

1.8

1.0

—

Medical observation and evaluation for suspected diseases and conditions

7.07

14.11

1.8

1.3

—

Mood disorders, excluding more controls

5.00

14.05

1.6

1.3

—

Anxiety disorders, excluding more controls

4.76

11.59

1.6

1.3

—

Mood [affective] disorders

3.87

11.19

1.5

1.2

—

Mood disorders

3.86

11.16

1.5

1.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

7.43

10.14

1.7

1.5

—

Hypothyroidism, drug reimbursement

+∞

9.97

1.9

0.0

—

Depression

3.74

9.45

1.6

1.2

—

Depression or dysthymia

5.52

8.76

2.0

1.4

—

Thyroiditis, ILD-related definition

20.04

8.46

1.3

—

Anxiety (asthma-related co-morbidities)

4.36

8.27

1.1

1.2

—

Autoimmune diseases related-to ILD

3.45

8.25

1.8

1.2

—

All anxiety disorders

4.13

8.16

1.1

1.3

—

Thyrotoxicosis, other and/or unspecified

13.02

7.86

1.8

1.1

—

Neurotic, stress-related and somatoform disorders

3.28

7.50

1.6

1.2

—

Anxiety disorders

3.22

7.28

1.6

1.2

—

Thyrotoxicosis with diffuse goitre

20.03

7.13

1.4

1.0

—

Other antidepressants

3.50

6.90

1.6

1.4

—

Other anxiety disorders

4.09

6.17

1.1

1.3

—

Pain in joint

3.87

6.11

2.0

1.2

—

Disorders of other endocrine glands

3.77

6.08

2.1

1.1

—

Iron deficiency anaemia

3.90

6.01

1.4

1.5

—

Any reimbursement code in KELA

5.01

5.87

2.4

1.0

—

Disorders of thyroid, IBD co-morbidities

9.38

5.86

1.6

1.1

—

Any mental disorder

3.14

5.72

1.6

1.3

—

Nutritional anaemias

3.54

5.56

1.3

1.4

—

Low back pain

3.16

5.31

1.8

1.2

—

Autoimmune hyperthyroidism

+∞

5.21

1.6

0.0

—

Recurrent or chronic depression

6.53

5.20

1.1

1.5

—

Thyrotoxicosis

5.19

5.07

1.7

—

Selective serotonin reuptake inhibitors

3.06

4.98

1.7

1.4

—

Carbimazole or st.post thyroidectomy, condition for graves disease

6.01

4.90

1.4

2.0

—

Other specific joint derangements/joint disorders

2.86

4.61

1.8

1.2

—

Graves disease, strict definition

8.20

4.56

1.4

2.8

—

Spondylosis

3.60

4.55

2.1

1.1

—

Psychiatric diseases

3.06

4.53

1.7

1.3

—

Other nutritional deficiencies

2.90

4.52

1.0

1.4

—

Intracranial injury

3.04

4.42

1.0

1.5

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

7.51

4.35

1.8

2.5

—

Other metabolic disorders

7.51

4.35

1.8

2.5

—

Non-selective monoamine reuptake inhibitors

5.03

4.30

2.3

1.4

—

Neurological diseases, wide definition

6.03

4.26

2.8

1.1

—

Atopic dermatitis

3.01

4.21

1.2

1.4

—

Other and unspecified iron deficiency

4.00

4.08

1.4

1.5

—

Urticaria

4.20

4.00

1.5

1.6

—

Urticaria and erythema

3.89

3.98

1.5

1.6

—

Spondylopathies

2.84

3.92

1.8

1.1

—

Excluding asthma or asthma-COPD overlap

2.95

3.91

2.1

1.1

—

Other pulmonary diagnosis

2.95

3.91

2.1

1.1

—

Exposure to unspecified factor

2.40

3.90

1.6

1.2

—

Sleep apnoea

2.57

3.85

1.7

1.3

—

Tramadol

2.65

3.85

1.1

1.2

—

Bipolar affective disorders

6.01

3.81

1.0

1.4

—

Faecal incontinence

8.76

3.77

1.6

1.1

—

Migraine

3.02

3.76

2.1

1.2

—

Antihypertensive medication - note that there are other indications

3.26

3.72

2.6

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.73

3.66

1.2

1.4

—

COPD differential diagnosis

2.88

3.61

2.2

1.1

—

ILD differential diagnosis

2.88

3.61

2.2

1.1

—

Schizophrenia or delusion, excluding more controls

4.72

3.51

1.0

1.4

—

Soft tissue disorders

2.38

3.42

1.8

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

2.88

3.37

2.3

1.1

—

Nonorganic sleeping disorders, excluding more controls

7.00

3.36

1.6

1.7

—

Episodal and paroxysmal disorders

2.32

3.36

1.9

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4.98

3.35

1.0

1.3

—

Exclusions for E4_PCOS_BROAD

5.71

3.33

3.3

1.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2.39

3.31

1.4

—

Lower back pain or/and sciatica

2.23

3.31

1.7

1.2

—

Persons encountering health services for examination and investigation

3.34

3.31

2.3

1.3

—

Caries of dentine

6.81

3.29

3.0

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

4.38

3.28

2.4

1.1

—

Other dorsopathies, not elsewhere classified

2.37

3.27

1.9

1.2

—

Abnormalities of breathing

2.41

3.20

1.7

1.2

—

Persons encountering health services in other circumstances

3.32

3.19

1.1

1.4

—

Other reaction to severe stress, and adjustment disorders

3.79

3.18

1.2

1.4

—

Diabetes, varying definitions

2.25

3.17

1.3

—

Neurological diseases

2.58

3.16

2.1

1.2

—

Diabetes mellitus

2.25

3.15

1.3

—

Sleep disorders (combined)

2.24

3.15

1.8

1.2

—

Poisoning by medicine

4.00

3.08

1.0

1.9

—

Dorsopathies

2.30

3.07

1.9

1.2

—

Pruritus

7.51

3.05

1.3

2.8

—

Type 2 diabetes, wide definition

2.56

3.03

1.4

—

Other disorders of fluid, electrolyte and acid-base balance

3.61

3.01

1.0

1.7

—

Other and unspecified nonorganic psychotic disorders

4.29

2.99

1.0

2.2

—

Other intervertebral disc disorders

2.49

2.98

2.0

1.2

—

Osteoporosis with pathological fracture (FG)

10.01

2.98

1.2

1.0

—

Disorders of mineral metabolism

10.01

2.98

1.0

1.8

—

Vestibular neuronitis

10.01

2.98

3.8

1.8

—

Asthma

2.70

2.97

1.2

1.1

—

Poisoning by drugs, medicaments and biological substances

3.85

2.97

1.0

1.8

—

Abnormalities of heart beat

3.27

2.94

1.2

—

Dental caries

5.61

2.92

3.0

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.20

2.91

1.9

1.2

—

Diabetes medication

2.15

2.87

1.4

1.3

—

Type 2 diabetes, strict (exclude DM1)

2.27

2.85

1.4

1.3

—

Type 2 diabetes, definitions combined

2.27

2.85

1.4

1.3

—

Dermatitis and eczema

2.09

2.84

1.5

1.3

—

Kela-code for severe mental illness

3.16

2.84

1.0

1.7

—

Nerve, nerve root and plexus disorders

2.13

2.83

1.8

1.2

—

Headache

2.47

2.83

1.3

1.2

—

Dyspnoea

2.20

2.81

1.7

1.2

—

Obesity due to excess calories

2.77

2.81

1.0

1.5

—

Sleep apnoea, including avohilmo

2.23

2.80

1.9

1.2

—

Other and unspecified urticaria

4.45

2.79

1.9

—

Disorders of synovium and tendon

2.78

2.75

1.0

1.1

—

Abnormal results of function studies

8.34

2.75

1.0

2.0

—

Flat foot [pes planus] (acquired)

8.34

2.75

1.0

—

Intracranial trauma

2.73

2.74

1.0

1.2

—

Other headache syndromes

3.00

2.68

2.7

1.1

—

Dorsalgia

2.22

2.68

1.8

1.2

—

Asthma (mode)

2.60

2.65

1.3

1.1

—

2.07

2.65

1.8

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

2.17

2.62

1.8

1.2

—

Dizziness and giddiness

2.30

2.61

1.0

1.5

—

Nontoxic multinodular goitre

4.67

2.59

1.1

—

Persistent mood disorders

4.67

2.59

1.7

1.4

—

Cardiac arrhythmias

2.68

2.59

1.4

1.6

—

Postmenopausal osteoporosis with pathological fracture

7.15

2.55

1.2

1.7

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.11

2.54

1.0

1.5

—

Other disorders of lacrimal gland

2.73

2.54

1.1

1.6

—

Unspecified mental disorder

2.73

2.54

1.0

1.6

—

Schizophrenia or delusion

3.23

2.51

1.0

1.8

—

Lumbar disc prolapse

2.56

2.49

2.1

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

2.98

2.48

1.0

1.3

—

Traumatic subdural haemorrhage

6.86

2.47

1.0

1.3

—

Personality disorders, excluding more controls

4.38

2.47

1.1

1.4

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

3.81

2.46

2.8

1.3

—

Hypo-osmolality and hyponatraemia

4.35

2.46

1.0

1.3

—

Constipation

2.16

2.46

1.2

1.4

—

Disorders of vestibular function (Vertigo)

2.56

2.44

2.3

1.2

—

Diseases of the respiratory system

2.59

2.44

2.3

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

2.15

2.43

1.4

1.3

—

Concussion

2.72

2.42

1.0

1.2

—

Spinal stenosis

2.98

2.40

2.3

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

2.04

2.39

1.4

—

Problems related to lifestyle

6.25

2.37

1.0

2.0

—

Hypokalaemia

6.25

2.37

1.0

1.5

—

Asthma, excluding more controls

2.52

2.36

1.2

1.1

—

Type 2 diabetes

2.07

2.36

1.4

—

Schizophrenia, schizotypal and delusional disorders

3.03

2.35

1.0

1.8

—

Examination and observation for other reasons

3.03

2.34

1.0

1.3

—

Metabolic disorders

2.14

2.34

1.3

1.4

—

Implicit Sepsis

2.25

2.34

2.2

1.2

—

Presence of other functional implants

2.58

2.30

1.1

1.7

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.56

2.28

1.0

2.3

—

Nontoxic goitre/thyroid nodule

2.94

2.27

1.1

1.7

—

Other (not insulin) diabetes medications

2.08

2.27

1.4

1.3

—

Other/unspecified dorsalgia

2.92

2.25

2.7

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

2.21

2.25

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.47

2.22

1.7

1.3

—

Injuries to the head

1.94

2.21

1.1

1.4

—

Carcinoma in situ of breast, intraductal

5.56

2.21

1.0

1.7

—

Spondylopathies (FG)

5.56

2.21

3.8

1.2

—

Other degenerative diseases of the nervous system

3.52

2.20

1.0

1.2

—

Other arrhythmias

2.31

2.19

1.4

—

Caries of enamel

2.03

2.16

2.0

1.2

—

Substance abuse, excluding more controls

3.07

2.15

1.3

—

Fracture of skull and facial bones

3.69

2.15

1.3

2.3

—

Hypertension, essential

2.36

2.14

2.5

1.1

—

Obesity related asthma

2.78

2.13

1.0

1.6

—

Osteoporosis

3.00

2.13

1.1

1.3

—

Arthropathies

2.05

2.12

2.1

1.2

—

Diseases of the skin and subcutaneous tissue

2.01

2.11

2.1

1.1

—

Osteopathies and chondropathies

2.29

2.10

2.2

1.2

—

Injuries to the neck

3.20

2.09

1.0

1.9

—

Missing teeth due to accident, extraction or parodontitis

2.27

2.08

1.0

1.5

—

Oxycodone

2.74

2.07

2.4

1.2

—

Carpal tunnel syndrome

2.29

2.07

1.1

1.2

—

Chronic laryngitis and laryngotracheitis

5.00

2.07

1.6

1.4

—

Acute upper respiratory infections

1.91

2.06

1.8

1.2

—

Atopic dermatitis, strict definition with reimbursement

2.90

2.05

1.0

1.6

—

severe traumatic brain injury, does not include concussion

4.00

2.04

1.0

1.7

—

Caries of dentine, including avohilmo

2.14

2.03

2.2

1.2

—

Acute sinusitis

2.41

2.01

2.6

1.2

—

Suicide or other Intentional self-harm

3.08

2.01

1.0

1.8

—

Pneumonia, organism unspecified

1.97

2.00

1.0

1.5

—

Diseases of the musculoskeletal system and connective tissue

2.62

2.00

2.7

1.1

—

Obesity

2.16

2.00

1.0

1.4

—

Disorders of adult personality and behaviour

2.81

1.99

1.1

1.8

—

Obesity and other hyperalimentation

2.16

1.99

1.0

1.4

—

2.38

1.98

1.2

1.5

—

Persons with potential health hazards related to communicable diseases

2.61

1.97

1.0

1.7

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.49

1.97

2.5

1.1

—

Mycoses

1.97

1.3

—

External causes of morbidity and mortality

2.23

1.97

2.2

1.3

—

Diseases of inner ear

2.29

1.97

2.3

1.2

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.34

1.96

1.0

2.0

—

Nonorganic sleeping disorders

3.33

1.96

1.6

2.0

—

Diseases of the ear and mastoid process

1.88

1.96

1.9

1.1

—

Spondyloarthritis

4.55

1.94

3.8

1.4

—

Accidents

2.10

1.94

2.0

1.3

—

Other symptoms and signs involving the digestive system and abdomen

3.75

1.93

1.0

1.1

—

Asthma (only as main-diagnosis), excluding more controls

2.40

1.93

1.2

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

4.94

1.93

1.8

1.0

—

Asthma, hospital admission 2, infections

2.18

1.91

1.1

1.4

—

Asthma-related infections

2.18

1.91

1.1

1.4

—

Factors influencing health status and contact with health services

4.30

1.90

2.0

1.0

—

Dental caries, including avohilmo

2.12

1.89

2.2

1.2

—

Implicit Sepsis

2.04

1.87

2.2

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2.65

1.86

1.0

1.7

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.53

1.84

1.1

1.6

—

Stomatitis and related lesions

3.53

1.83

1.0

2.2

—

Other disorders of the musculoskeletal system and connective tissue

4.17

1.82

3.8

1.5

—

4.17

1.82

1.0

1.5

—

Recurrent aphthous stomatitis , including avohilmo

4.17

1.82

1.0

1.5

—

Disorders of psychological development

4.22

1.82

1.0

1.8

—

Atopic dermatitis, strict definition

2.59

1.81

1.0

1.7

—

Disorders of lacrimal system

2.26

1.79

1.1

1.5

—

Coxibs

3.35

1.78

1.4

1.0

—

First line medication for Crohn's disease

1.83

1.78

2.0

1.1

—

Other diseases of lip and oral mucosa

2.34

1.77

1.4

1.5

—

Asthma (only as main-diagnosis)

2.28

1.76

1.2

1.1

—

Disorders of gallbladder, biliary tract and pancreas

1.88

1.75

1.9

1.2

—

Syncope and collapse

2.35

1.74

2.4

1.2

—

Candidiasis

2.50

1.73

1.2

1.5

—

Tonsillectomy and adenotomy

2.21

1.72

1.1

1.7

—

Cervical disc disorders

2.92

1.72

3.0

1.2

—

Other soft tissue disorders, not elsewhere classified

1.95

1.71

2.1

1.1

—

Allergic asthma (mode)

3.26

1.70

1.3

1.1

—

Allergic asthma (mode), excluding more controls

3.26

1.70

1.3

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.84

1.68

1.0

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.81

1.68

2.1

1.1

—

Myalgia

3.16

1.66

3.3

1.2

—

Hypertensive diseases (excluding secondary)

2.53

1.65

3.2

1.2

—

Symptoms and signs involving the urinary system

1.97

1.64

1.9

1.3

—

Chronic lower respiratory diseases

1.75

1.64

1.2

1.4

—

Bronchitis

1.78

1.63

1.3

—

Biguanides

1.87

1.62

1.4

1.3

—

Other external causes of accidental injury

1.98

1.62

2.1

1.3

—

Cholelithiasis

1.92

1.61

2.0

1.2

—

Allergic contact dermatitis

3.57

1.61

1.2

2.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.57

1.61

1.0

2.1

—

Other bacterial intestinal infections

3.57

1.61

1.2

1.1

—

Cervicobrachial syndrome

3.57

1.61

1.4

1.1

—

Other disorders of urethra and urinary system

2.00

1.61

1.3

1.2

—

COPD/asthma related infections

1.85

1.60

1.9

1.2

—

COPD/asthma/ILD related infections

1.85

1.60

1.9

1.2

—

Use of hypnotics and sedatives

1.80

1.59

1.1

1.4

—

Complications of medical and surgical care

1.91

1.58

2.0

1.2

—

Other gastritis (incl. Duodenitis)

3.00

1.58

2.0

1.9

—

Other bacterial intestinal infections

3.00

1.58

1.2

—

Other problems related to primary support group, including family circumstances

3.48

1.57

1.0

2.4

—

COPD

2.52

1.57

1.1

1.2

—

Open wound of head

2.21

1.57

1.0

1.6

—

Other and unspecified dermatitis

2.20

1.56

1.7

1.4

—

Convulsions, not elsewhere classified

2.66

1.55

1.0

1.3

—

Pneumonias (Asthma/COPD co-morbidities)

1.79

1.55

1.0

1.4

—

1.91

1.54

1.0

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.91

1.54

1.0

1.2

—

ILD medications

1.75

1.53

2.1

1.1

—

All pneumoniae

1.78

1.53

1.0

1.4

—

Contact with and exposure to communicable diseases

2.41

1.52

1.0

1.8

—

Insulin, fast-acting (human)

3.33

1.52

1.2

2.5

—

Dislocation, sprain and strain of joints and ligaments at neck level

3.33

1.52

1.0

2.5

—

Polyuria

3.33

1.52

1.0

1.6

—

Bacterial intestinal infections, IBD co-morbidities

3.33

1.52

1.2

2.4

—

Organic, including symptomatic, mental disorders

2.24

1.52

1.1

1.3

—

Pain in limb

1.97

1.52

1.3

1.2

—

Cholelithiasis, broad definition with cholecystitis

1.88

1.51

2.0

1.2

—

Primary coxarthrosis, bilateral

2.59

1.51

1.4

1.3

—

Disorders of refraction and accommodation

2.58

1.50

1.0

1.8

—

Other acute lower respiratory infections

2.08

1.49

1.2

1.5

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.00

1.48

2.1

1.2

—

Disorders of parathyroid gland

2.82

1.48

1.2

1.3

—

Complications of surgical and medical care, not elsewhere classified

1.76

1.47

1.9

1.2

—

Malaise and fatigue

2.16

1.45

2.3

1.2

—

Voice disturbances

2.50

1.45

1.0

1.8

—

Gastrointestinal diseases

2.10

1.44

2.7

1.2

—

Certain disorders involving the immune mechanism

3.13

1.44

3.8

1.4

—

Asthma (diagnoses ohter than nonallergic)

1.78

1.43

1.3

—

Female genital prolapse

0.00

1.41

0.0

1.2

—

Hypertensive diseases

1.98

1.39

2.6

1.1

—

Hypertension

1.98

1.39

2.6

1.1

—

Asthma, unspecified (mode)

2.26

1.38

1.3

1.1

—

Adjustment and management of implanted device

2.94

1.36

1.4

1.5

—

Other and unspecified nerve root and plexus disorders, also in other diseases

2.94

1.36

1.0

1.1

—

Pediculosis, acariasis and other infestations

2.94

1.36

1.0

2.3

—

Acetic acid derivatives and related substances

2.83

1.36

1.7

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

2.94

1.36

1.0

2.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.52

1.33

1.0

1.3

—

Dermatophytosis

1.97

1.32

1.2

1.4

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.96

1.32

2.2

1.2

—

Sciatica+with lumbago

2.12

1.31

2.8

1.1

—

Chronic diseases of tonsils and adenoids

1.86

1.31

2.1

1.1

—

Diagnoses used for exclusion with ILD

2.50

1.30

1.3

2.0

—

Persons encountering health services in other circumstances, wide

1.67

1.30

1.7

1.3

—

Pacemaker

2.40

1.30

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.40

1.30

1.0

1.7

—

Oedema, not elsewhere classified

2.39

1.30

2.9

1.2

—

In situ neoplasms

2.09

1.30

1.1

1.6

—

Other diseases of upper respiratory tract

1.68

1.29

2.1

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

2.78

1.28

1.0

2.2

—

Focal epilepsy, strict definition

2.78

1.28

1.0

2.2

—

Type 1 diabetes, wide definition, subgroup 1

2.78

1.28

1.2

1.9

—

Autoimmune diseases excluding thyroid diseases

1.97

1.28

1.6

1.1

—

2.77

1.27

2.0

1.2

—

Symptoms and signs involving speech and voice

2.29

1.26

1.0

1.7

—

Diseases of external ear

2.29

1.26

1.3

1.6

—

Heart failure, strict

2.04

1.25

1.0

1.2

—

Postmenopausal atrophic vaginitis

0.00

1.22

0.0

1.2

—

Chronic periodontitis, including avohilmo

1.70

1.21

1.4

—

Ectopic pregnancy

2.63

1.21

1.0

1.8

—

Parasetamol

1.94

1.21

2.5

1.2

—

Other heart diseases, wide

1.73

1.20

1.4

—

Asthma/COPD (KELA code 203)

1.69

1.20

1.1

1.4

—

Asthma, unspecified (mode), excluding more controls

2.14

1.18

1.1

—

Chronic sinusitis

2.10

1.18

1.3

1.1

—

Presence of cardiac and vascular implants and grafts

2.12

1.17

1.3

—

Visual disturbances

1.93

1.16

1.1

1.5

—

Other diseases of hard tissues of teeth

2.03

1.16

1.3

1.2

—

Periodontitis

1.67

1.16

1.4

—

Endometriosis ASRM stages 3,4

0.00

1.16

0.0

1.6

—

Injuries to the ankle and foot

1.78

1.15

2.0

1.2

—

Other joint disorders

1.72

1.15

2.2

1.2

—

Diseases of salivary glands

2.05

1.15

1.0

1.6

—

Focal epilepsy

2.50

1.15

1.0

2.1

—

General symptoms and signs

1.67

1.15

2.0

1.2

—

Cholecystectomy

1.78

1.15

2.1

1.2

—

Maternal care for known or suspected fetal abnormality and damage

2.53

1.14

1.0

2.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.81

1.13

1.1

1.5

—

Chronic periodontitis, complicated

1.98

1.13

1.0

1.5

—

Intestinal infectious diseases

1.65

1.12

2.2

1.1

—

Non-ischemic cardiomyopathy

2.35

1.12

1.3

1.2

—

Diseases of liver

2.33

1.12

1.0

1.8

—

Other diseases of the digestive system

2.33

1.12

1.3

1.8

—

Influenza and pneumonia

1.61

1.12

1.0

1.4

—

Other chronic obstructive pulmonary disease

2.31

1.11

1.0

1.2

—

Menorrhagia

2.06

1.11

1.6

1.1

—

COPD (mode)

2.45

1.10

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.70

1.10

2.2

1.2

—

Alcohol dependence

2.38

1.09

1.0

2.1

—

Otitis externa

2.38

1.09

1.0

2.0

—

Cardiovascular diseases

1.90

1.08

2.8

1.1

—

Gingivitis and periodontal diseases

1.61

1.08

1.4

1.3

—

Personality disorders

2.19

1.08

1.1

1.7

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.19

1.08

1.0

1.7

—

Abrasion of teeth

2.19

1.08

1.1

1.8

—

COPD related to multimorbidity

2.19

1.07

1.0

1.3

—

Coxarthrosis [arthrosis of hip](FG)

2.04

1.06

1.3

1.2

—

Pain, not elsewhere classified

2.12

1.05

3.3

1.2

—

Opioids

1.62

1.05

2.1

1.2

—

Gastro-oesophageal reflux disease

1.75

1.03

1.0

1.4

—

Type 1 diabetes, wide definition

2.27

1.03

1.2

1.8

—

Diseases of the digestive system

1.95

1.03

1.2

1.6

—

Benign paroxysmal vertigo

2.06

1.02

1.1

1.2

—

Alcohol use disorder, ICD-based

2.06

1.02

1.0

1.8

—

Visual disturbances and blindness

1.83

1.02

1.1

1.5

—

Pollen allergy

2.24

1.01

1.2

2.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.68

1.01

2.3

1.2

—

Triptan medication for migraine, min. 3 purchases

1.80

1.01

2.2

1.2

—

Diseases of the eye and adnexa

1.75

1.00

1.5

—

Sleep disorders

1.62

1.00

1.2

1.4

—

Acute bronchitis

1.88

1.00

1.2

1.5

—

Noninfective enteritis and colitis

1.83

0.98

2.6

1.3

—

Car occupant injured in other and unspecified transport accidents

2.17

0.98

1.0

2.1

—

Triptan medication for migraine, single purchase ok

1.67

0.98

2.1

1.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.67

0.98

2.1

1.2

—

COPD, hospital admissions

1.97

0.97

1.0

1.3

—

COPD, early/later onset

1.97

0.97

1.0

1.3

—

Preterm labour and delivery

0.00

0.97

0.0

1.7

—

Cystitis

1.64

0.96

1.9

1.2

—

Substance abuse

1.80

0.96

1.3

1.5

—

Disease of hard tissues of teeth, NOS

1.94

0.96

1.0

1.2

—

Conduction disorders

2.32

0.95

1.0

1.8

—

Complications of procedures, not elsewhere classified

1.63

0.95

2.0

1.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.84

0.94

1.0

1.5

—

Any gastric operation

1.64

0.93

2.0

1.3

—

GASTRO-related operations

1.64

0.93

2.0

1.3

—

Mental and behavioural disorders due to psychoactive substance use

1.74

0.92

1.3

1.5

—

Ischaemic heart disease, wide definition

1.71

0.92

1.4

1.5

—

All-cause Heart Failure

1.86

0.92

1.0

1.2

—

Fall on and from stairs and steps

2.14

0.91

1.0

1.7

—

ILD medications: immunosuppressive drugs

1.76

0.91

1.2

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.67

0.91

2.5

1.2

—

Finngen Rheumatological endpoints

1.58

0.90

2.3

1.2

—

Fracture of femur

2.09

0.90

1.2

1.4

—

Specific personality disorders

2.07

0.89

1.0

1.8

—

Mycoses

2.07

0.89

1.0

1.8

—

Dermatitis

1.74

0.89

1.7

1.3

—

Asthma, including avohilmo

1.49

0.88

1.9

1.2

—

Other abnormal uterine and vaginal bleeding

2.05

0.87

1.0

1.1

—

Abnormal findings on diagnostic imaging of lung

1.87

0.87

1.1

1.5

—

Renal failure

1.86

0.87

1.0

1.7

—

Erosion of teeth , including avohilmo

2.00

0.87

1.0

1.7

—

Other and unspecified effects of external causes

2.00

0.87

3.3

1.4

—

Heart failure and bmi 25plus

2.03

0.86

1.0

1.1

—

Dementia

1.83

0.86

1.1

1.3

—

Noninflammatory disorders of female genital tract

1.78

0.84

2.8

1.1

—

Injury, poisoning and certain other consequences of external causes

1.78

0.84

2.8

1.3

—

Oral corticosteroids

1.50

0.83

1.5

1.3

—

Bleeding

1.61

0.82

1.1

1.5

—

Fall on same level

1.50

0.82

1.2

1.4

—

Other chronic obstructive pulmonary disease, including avohilmo

1.74

0.82

1.0

1.6

—

Retinal detachments and breaks

1.88

0.81

1.0

1.6

—

Medicines for HER+ breast cancer

1.72

0.81

1.0

1.6

—

Vasomotor and allergic rhinitis

1.84

0.80

1.2

—

Inflammatory bowel disease

1.82

0.79

1.0

1.8

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.67

0.78

1.1

1.2

—

Intestinal infectious diseases

1.46

0.78

2.1

1.2

—

Alcohol use disorder, Swedish definition

1.67

0.78

1.0

1.6

—

Symptoms and signs involving the skin and subcutaneous tissue

1.59

0.78

1.4

1.3

—

Senile cataract

1.78

0.78

1.4

1.1

—

N06DA Anticholinesterases

1.82

0.78

1.2

1.3

—

Use of anticholinesterases

1.82

0.78

1.2

1.3

—

Coxarthrosis, primary

1.73

0.78

1.3

1.5

—

Haemorrhage in early pregnancy

1.77

0.76

1.3

1.6

—

Other disorders of skin and subcutaneous tissue

1.58

0.76

2.2

1.2

—

Other disorders of ear

1.52

0.76

1.4

—

Malignant neoplasm of breast, HER-positive

1.88

0.74

1.0

1.3

—

Polyarthropathies

1.67

0.74

1.2

—

Malignant neoplasm of breast, ER-positive, including Hilmo

1.86

0.74

1.0

1.3

—

Diseases of oral cavity, salivary glands and jaws

1.65

0.74

1.7

1.2

—

Excessive, frequent and irregular menstruation

1.64

0.73

1.7

1.1

—

Chronic kidney disease

2.04

0.73

1.0

1.4

—

Other cataract

1.83

0.73

1.7

1.6

—

Other benign neoplasms of skin

1.84

0.73

1.6

1.5

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.83

0.73

1.0

1.7

—

Impacted teeth

2.02

0.73

1.0

2.1

—

Polyarthrosis

2.02

0.73

1.8

1.2

—

Infections of the skin and subcutaneous tissue

1.62

0.72

1.4

—

Pulmonary heart disease

2.00

0.72

1.4

1.9

—

Pulmonary embolism

2.00

0.72

1.4

1.9

—

Falls/tendency to fall

1.48

0.72

1.2

1.5

—

Type 1 diabetes

2.00

0.72

1.2

1.7

—

Papulosquamous disorders

1.80

0.72

1.6

1.5

—

L02BG Aromatase inhibitors

1.79

0.72

1.0

1.7

—

Asthma-related pneumonia

1.79

0.72

1.0

1.6

—

Asthma-related pneumonia or sepsis

1.79

0.72

1.0

1.6

—

Asthma, hospital admissions 3, pneumonia

1.79

0.72

1.0

1.6

—

Disorders of sclera, cornea, iris and ciliary body

1.61

0.72

1.1

1.5

—

Diabetic retinopathy, excluding more controls

1.78

0.72

1.7

1.3

—

Insulin, fast-acting or short human

1.75

0.71

1.1

1.7

—

Insulin, fast-acting

1.75

0.71

1.1

1.6

—

DVT of lower extremities and pulmonary embolism

1.74

0.71

1.9

1.5

—

Subjective visual disturbances

1.92

0.70

1.2

1.8

—

Pain (limb, back, neck, head abdominally)

1.67

0.70

3.1

1.2

—

Epilepsy

1.92

0.70

1.0

1.2

—

Basal cell carcinoma, including avohilmo

1.72

0.70

1.7

1.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.69

0.68

1.3

—

Stroke, excluding SAH

1.66

0.68

1.0

1.6

—

Symptoms and signs involving the digestive system and abdomen

1.47

0.67

2.2

1.2

—

Malignant neoplasm of skin

1.65

0.67

1.7

1.2

—

Other abnormal products of conception

1.65

0.67

1.1

1.5

—

Mental and behavioural disorders due to alcohol

1.64

0.67

1.0

1.6

—

Open wound of wrist and hand

1.63

0.66

3.0

1.3

—

Injuries to the elbow and forearm

1.52

0.66

1.0

1.4

—

Deforming dorsopathies

1.79

0.66

4.0

1.1

—

All influenza

1.79

0.66

1.0

1.8

—

COPD, hospital admission 2, with asthma infections

1.79

0.66

1.0

1.3

—

Covid-19 confirmed case

1.59

0.65

1.3

1.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.44

0.64

2.2

1.2

—

Transport accidents

1.58

0.64

1.0

1.3

—

Other neurological diseases

1.55

0.64

2.3

1.2

—

Diseases of middle ear and mastoid

1.58

0.64

1.4

1.5

—

Dentofacial anomalies [including malocclusion]

1.51

0.64

2.6

1.1

—

1.74

0.64

2.2

1.2

—

Implicit viral Sepsis

1.72

0.64

1.0

1.2

—

Ovarian cyst

1.65

0.63

1.0

1.1

—

Heart failure,strict

1.66

0.63

1.0

1.2

—

Shoulder lesions

1.59

0.62

2.5

1.1

—

Infections with a predominantly sexual mode of transmission

1.62

0.61

1.5

—

L04AX Other immunosuppressants

1.59

0.61

1.2

1.4

—

Cutaneous abscess, furuncle and carbuncle

1.67

0.61

1.8

1.7

—

GI-bleeding

1.67

0.61

1.0

1.7

—

Pulmonary heart disease, diseases of pulmonary circulation

1.67

0.61

1.4

1.8

—

Aplastic and other anaemias

1.59

0.61

1.5

1.4

—

Polycystic ovarian syndrome, consortium definition

1.46

0.60

1.5

1.3

—

Endometriosis of ovary

0.00

0.60

0.0

1.2

—

Sub-endpoint used in defining T1D endpoints

1.64

0.60

1.2

1.9

—

Seborrhoeic keratosis

0.00

0.60

0.0

1.3

—

Fever of other and unknown origin

1.55

0.59

1.0

1.2

—

Temporomandibular joint disorders, including avohilmo

1.55

0.59

3.4

1.2

—

Genitourinary diseases

1.54

0.59

1.8

1.3

—

Any dementia, excluding more controls

1.80

0.59

1.2

1.3

—

1.54

0.59

1.0

1.6

—

Alzheimer disease, including avohilmo

1.76

0.59

1.0

1.4

—

Procreative management

1.72

0.58

3.7

1.4

—

Other heart diseases

1.70

0.57

1.0

1.2

—

Irritable bowel syndrome

1.71

0.57

3.3

1.3

—

Haemorrhage from respiratory passages

1.69

0.57

1.0

1.2

—

Asthma, hospital admissions , main diagnosis only

1.44

0.56

1.2

1.3

—

Mouth breathing

1.66

0.56

3.3

1.3

—

1.47

0.56

1.0

1.6

—

Disorders of lens

1.56

0.56

1.4

1.5

—

Fracture of lower leg, including ankle

1.55

0.56

1.0

1.5

—

Appendicitis, broad definition

0.57

0.56

1.4

—

Diseases of appendix

0.56

1.4

—

Second line medication for Crohn's disease

1.54

0.55

1.2

1.4

—

Leiomyoma of uterus

0.61

0.54

1.0

1.4

—

Codes for special purposes

1.50

0.54

1.2

1.5

—

Provisional assignment of new diseases of uncertain etiology

1.50

0.54

1.2

1.5

—

Benign neoplasm of colon, rectum, anus and anal canal

1.47

0.53

1.4

1.5

—

Stroke, including SAH

1.45

0.53

1.0

1.6

—

Diabetic retinopathy

1.62

0.50

1.7

1.2

—

Disorders of breast

1.38

0.50

1.0

1.5

—

Sensorineural hearing loss

1.45

0.50

1.4

—

Fracture of forearm

1.50

0.50

1.0

1.5

—

Pure hypercholesterolaemia

1.52

0.49

1.2

1.5

—

All kidney diseases

1.37

0.49

1.0

1.4

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.38

0.49

1.3

1.4

—

Diseases of oesophagus, stomach and duodenum

1.36

0.49

1.4

—

Heart failure and coronary heart disease

1.55

0.49

1.0

1.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.36

0.49

1.8

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.55

0.48

1.0

1.3

—

Renal tubulo-interstitial diseases

1.39

0.48

1.0

1.4

—

Dementia, including avohilmo

1.50

0.48

1.1

1.3

—

Ischemic heart diseases

1.42

0.48

1.4

1.5

—

Unspecific neurodegenerative disorder

1.49

0.48

1.1

1.3

—

Degeneration of macula and posterior pole

1.39

0.44

1.9

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.45

0.44

2.5

1.2

—

Insomnia

1.36

0.43

1.0

1.4

—

Rotator cuff syndrome

1.43

0.43

3.0

1.1

—

Sequelae of external causes of morbidity and mortality

1.61

0.43

1.0

1.7

—

Injuries to the hip and thigh

1.45

0.43

1.1

1.5

—

Insulin, intermediate and long-acting

1.44

0.42

1.4

1.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.37

0.41

1.1

—

Diabetic maculopathy

0.00

0.41

0.0

1.3

—

Malignant neoplasm of bronchus and lung

0.00

0.41

0.0

1.1

—

Diabetic nephropathy, excluding more controls

0.00

0.41

0.0

1.4

—

Melanocytic naevi

1.52

0.41

1.8

1.5

—

Striking against or struck by other objects

1.51

0.41

1.0

1.8

—

Acne

0.00

0.41

0.0

2.2

—

Infections of genitourinary tract in pregnancy

0.00

0.41

0.0

2.2

—

LSIL lesion of the cervix uteri

0.00

0.41

0.0

2.3

—

Other condition

0.00

0.41

0.0

2.5

—

Pain in thoracic spine

0.00

0.41

0.0

1.2

—

Gestational [pregnancy-induced] hypertension

1.51

0.41

1.0

1.6

—

Puerperal sepsis

0.00

0.41

0.0

2.3

—

Acute appendicitis, with complications

0.00

0.41

0.0

2.4

—

Outcome of delivery

0.00

0.41

0.0

1.2

—

Gastric ulcer

0.00

0.40

0.0

1.2

—

Other viral diseases, not elsewhere classified

0.00

0.40

0.0

2.3

—

Unspecified haematuria

1.48

0.40

1.0

1.4

—

Degenerative diseases of the nervous system

1.47

0.40

1.0

1.4

—

Obesity, other/unspecified

1.47

0.40

1.0

1.7

—

Erysipelas

1.40

0.40

1.3

1.5

—

Other skin changes

0.00

0.40

0.0

1.2

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.40

0.0

2.0

—

Diabetic nephropathy

0.00

0.40

0.0

1.4

—

Congenital malformations, deformations and chromosomal abnormalities

1.42

0.40

1.0

1.4

—

Irregular menses

1.32

0.39

1.3

1.4

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.00

0.39

0.0

1.2

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.39

0.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.43

0.39

1.8

1.1

—

Implicit bacterial Sepsis

1.43

0.39

1.0

1.2

—

Inflammatory disease of uterus

0.00

0.39

0.0

2.1

—

malignant neoplasm of female genital organs

0.00

0.39

0.0

1.3

—

Malignant neoplasm

1.35

0.38

2.5

1.2

—

Internal derangement of knee

1.38

0.38

1.0

1.2

—

Other diseases of urinary system

1.32

0.38

2.2

1.2

—

Single spontaneous delivery

0.62

0.37

1.6

1.5

—

Delivery

0.61

0.37

1.6

1.5

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.35

0.37

1.0

1.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.32

0.37

1.1

1.4

—

Basal cell carcinoma

1.48

0.36

1.8

1.2

—

Other obstetric conditions, not elsewhere classified

1.47

0.36

1.0

1.7

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.47

0.36

1.0

1.7

—

Other retinal disorders

1.27

0.36

1.7

1.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.65

0.36

1.2

1.4

—

Any dementia

1.44

0.36

1.2

1.3

—

Arthrosis

1.41

0.36

1.6

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.42

0.35

1.8

1.2

—

Allergic conjunctivitis

0.65

0.35

1.2

1.4

—

Hernia of abdominal wall

1.43

0.35

1.0

1.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.40

0.35

1.8

1.2

—

Injuries to the knee and lower leg

1.25

0.35

1.0

1.4

—

Other diseases of pleura

1.38

0.35

3.5

1.2

—

Abnormal findings on examination of blood, without diagnosis

1.38

0.34

1.2

1.6

—

Injuries to the thorax

1.36

0.34

1.2

1.6

—

Disorders of choroid and retina

1.33

0.34

1.5

1.4

—

Periapical abscess

1.33

0.33

1.7

1.5

—

Implicit bacterial Sepsis

1.33

0.33

1.0

1.2

—

Other and unspecified anaemias

1.33

0.33

1.7

1.5

—

Other anaemias

1.33

0.33

1.7

1.5

—

Conductive and sensorineural hearing loss

1.33

0.33

1.4

—

Coxarthrosis, primary, with hip surgery

1.28

0.32

1.2

—

Complications of labour and delivery

0.71

0.32

1.3

1.4

—

Pregnancy hypertension

1.36

0.31

1.0

1.5

—

STROKE

1.32

0.31

1.0

1.6

—

Primary gonarthrosis, bilateral

1.33

0.31

1.0

1.6

—

Malignant neoplasm, wide definition for exclusion

1.29

0.30

2.4

1.2

—

Exposure to other specified factors

1.31

0.29

1.1

1.4

—

Spontaneous abortion

1.24

0.29

1.4

—

Excessive attrition of teeth

1.25

0.29

1.1

1.5

—

All chronic kidney diseases

1.24

0.29

1.0

1.6

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.24

0.29

1.0

1.5

—

Gonarthrosis, primary, with knee surgery

1.24

0.29

1.0

1.3

—

Medical abortion

1.30

0.29

1.3

1.4

—

Other functional intestinal disorders

1.23

0.29

3.0

1.2

—

Codeine

1.27

0.28

2.4

1.2

—

Persons encountering health services in circumstances related to reproduction

1.25

0.28

1.3

—

Fall on same level involving ice and snow

1.27

0.27

1.0

1.5

—

Disorders of eyelid, lacrimal system and orbit

1.27

0.27

1.3

1.4

—

Insulin medication

1.25

0.27

1.4

—

Congenital malformations, deformations and chromosomal abnormalities

1.23

0.27

1.0

1.5

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.69

0.26

1.2

1.4

—

Heart failure, not strict

1.25

0.26

1.4

1.5

—

Certain infectious and parasitic diseases

1.28

0.25

2.7

1.1

—

Any event in cancer register

1.25

0.25

2.5

1.2

—

Postmenopausal bleeding

1.33

0.24

1.4

1.2

—

Inflammatory bowel disease treatment related agents

1.20

0.24

1.6

1.3

—

Female infertility

1.32

0.23

1.0

1.1

—

Long labour

1.34

0.23

1.4

1.6

—

Embedded and impacted teeth

1.33

0.23

1.0

1.8

—

Allergic rhinitis

1.34

0.23

1.2

1.3

—

Liquid cancers, helper endpoint

1.28

0.23

1.2

—

Keratitis

1.28

0.23

1.0

1.7

—

Injuries to the shoulder and upper arm

1.24

0.22

1.0

1.4

—

Systemic connective tissue disorders

1.25

0.22

1.8

1.5

—

Solid cancers, helper endpoint

1.24

0.22

2.6

1.2

—

Skin changes due to chronic exposure to nonionizing radiation

1.21

0.22

1.0

1.3

—

Diseases of pulp and periapical tissues and dental caries

1.28

0.21

1.5

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

1.19

0.21

2.1

1.2

—

Congenital malformations of genital organs

0.00

0.21

0.0

3.0

—

Malignant neoplasm of corpus uteri

0.00

0.21

0.0

1.3

—

Other obstructed labour

0.00

0.21

0.0

2.8

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

3.0

—

Endometriosis of rectovaginal septum and vagina

0.00

0.21

0.0

1.2

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

0.21

0.0

1.3

—

Acne vulgaris

0.00

0.21

0.0

1.2

—

Infectious mononucleosis

0.00

0.21

0.0

1.4

—

Deep endometriosis

0.00

0.21

0.0

3.0

—

Ptosis of eyelid

0.00

0.21

0.0

1.7

—

Open wound of ankle and foot

0.00

0.21

0.0

1.6

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.21

0.0

3.0

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.21

0.0

1.7

—

Dialysis, with operation codes

0.00

0.21

0.0

1.6

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.6

—

Peripheral arterial reconstruction

0.00

0.21

0.0

1.6

—

Injury of muscle and tendon at wrist and hand level

0.00

0.21

0.0

1.7

—

Congenital malformations of heart and great arteries

0.00

0.21

0.0

1.7

—

Non-small cell lung cancer, including Hilmo

0.00

0.21

0.0

1.2

—

Mental disorders, not otherwise specified

0.00

0.21

0.0

2.8

—

Glaucoma, exfoliation

0.00

0.21

0.0

1.3

—

Other septicaemia

1.17

0.21

1.0

1.6

—

Lung cancer and mesothelioma

0.00

0.21

0.0

1.2

—

Infections with a predominantly sexual mode of transmission

1.16

0.21

1.2

1.6

—

Embedded teeth, including avohilmo

0.00

0.21

0.0

1.5

—

Postpartum haemorrhage due to anatomy

0.00

0.21

0.0

1.2

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

2.5

—

Macular pucker

0.00

0.21

0.0

1.2

—

Foreign body on external eye

0.00

0.21

0.0

1.5

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.20

0.0

2.4

—

Other sexually transmitted chlamydial diseases

0.00

0.20

0.0

2.4

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

0.20

0.0

1.1

—

Congenital malformations of the circulatory system

0.00

0.20

0.0

2.6

—

Coxarthrosis

1.20

0.20

1.5

1.2

—

Viral infections characterized by skin and mucous membrane lesions

1.22

0.20

1.2

1.5

—

Fracture of shoulder and upper arm

1.22

0.20

1.0

1.6

—

Codeine or tramadol medication

1.18

0.19

2.2

1.2

—

Disorders of skin appendages

1.18

0.19

2.2

1.4

—

Certain infectious and parasitic diseases

1.19

0.19

2.5

1.2

—

Malignant neoplasm of breast, HER2-negative

1.15

0.19

3.3

1.2

—

Malignant neoplasm of breast

1.15

0.19

3.3

1.2

—

Transient ischemic attack

1.21

0.18

1.1

1.5

—

Unspecified fall

1.21

0.18

1.0

1.6

—

Ischaemic Stroke, excluding all haemorrhages

1.16

0.18

1.0

1.6

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.14

0.17

1.0

1.6

—

Venous thromboembolism

1.17

0.17

1.9

1.4

—

Delivery, wide proxy

0.74

0.17

1.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.18

0.16

1.4

1.5

—

Gonarthrosis [arthrosis of knee](FG)

1.13

0.16

1.0

1.1

—

Other maternal disorders predominantly related to pregnancy

1.15

0.15

1.3

1.4

—

Diverticular disease of intestine

1.13

0.15

1.3

1.2

—

Cerebrovascular diseases

1.09

0.15

1.0

1.5

—

Pain in throat and chest

1.20

0.14

1.4

1.2

—

Neoplasms

0.84

0.13

3.2

1.1

—

Statin medication

1.20

0.13

1.7

1.5

—

Other bacterial diseases

1.14

0.11

1.1

1.4

—

Non-rheumatic valve diseases

1.16

0.10

1.0

1.6

—

Valvular heart disease excluding rheumatic fever

1.13

0.10

1.0

1.6

—

1.15

0.10

1.0

1.3

—

Hallux valgus (acquired)

1.12

0.10

1.0

1.2

—

Explicit Sepsis

1.14

0.10

1.0

1.1

—

Other disorders of veins

1.13

0.10

2.0

1.5

—

Bacterial pneumoniae

1.07

0.09

1.0

1.6

—

Other symptoms and signs involving cognitive functions and awareness

1.06

0.09

1.0

1.7

—

Angina pectoris

1.14

0.09

1.0

1.2

—

Other arthrosis

1.12

0.09

1.0

1.2

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1.08

0.09

3.3

1.2

—

Malignant neoplasm of breast, including Hilmo

1.08

0.09

3.3

1.2

—

Glucosamine medication

1.09

0.09

1.5

1.2

—

Major coronary heart disease event excluding revascularizations

1.05

0.08

1.7

1.2

—

Coronary atherosclerosis

0.81

0.08

1.2

—

Dental operations

1.12

0.08

1.9

1.2

—

Glaucoma

0.78

0.08

1.4

—

Zoster [herpes zoster]

0.78

0.08

1.0

1.4

—

Varicose veins

1.06

0.08

1.6

1.4

—

Exclusions for E4_PCOS_CONSORTIUM

1.12

0.08

1.3

—

Reimbursement for rheumatic diseases

0.85

0.07

1.3

1.4

—

Diseases of arteries, arterioles and capillaries

1.07

0.07

1.5

1.4

—

Care involving use of rehabilitation procedures

1.07

0.07

1.0

1.4

—

Percutaneous Coronary Intervention

1.02

0.07

1.4

1.5

—

Coronary revascularization (ANGIO or CABG)

1.02

0.07

1.4

1.5

—

Inflammatory diseases of female pelvic organs

0.86

0.07

1.0

1.4

—

Artificial joint operation, meniscal resection

1.10

0.05

1.0

1.5

—

Benign neoplasms

0.92

0.04

1.5

1.3

—

Hard cardiovascular diseases

1.10

0.04

1.4

1.5

—

Hernia

0.92

0.04

1.0

1.4

—

Persons encountering health services for specific procedures and health care

0.94

0.02

1.0

1.4

—

Dental pulpitis, including avohilmo

0.93

0.02

2.5

1.2

—

Artrosis, including avohilmo

1.07

0.02

1.5

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.07

0.02

1.4

1.3

—

Viral infections characterized by skin and mucous membrane lesions

1.02

0.00

1.3

—

Emergency coronary revascularization (for ACS)

1.01

0.00

1.4

—

Abdominal and pelvic pain

1.04

0.00

2.4

1.2

—

Other bacterial diseases

0.97

0.00

1.1

1.4

—

Injuries to the wrist and hand

1.03

0.00

2.2

1.2

—

Disorders of conjunctiva

1.05

0.00

1.1

1.4

—

Major coronary heart disease event

1.01

0.00

1.4

—

Chronic apical periodontitis

1.03

0.00

1.3

—

Other diseases of intestines

1.03

0.00

2.1

1.2

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

1.4

—

Other viral hepatitis

0.00

0.0

2.3

—

Viral infections of the central nervous system

0.00

0.0

2.2

—

Non-allergic asthma

0.00

0.0

1.8

—

Disorders of vitreous body and globe

0.92

0.00

1.2

1.5

—

Presbyopia

0.00

0.0

5.0

—

Memory loss

0.00

0.0

1.8

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.0

3.5

—

L01XE Protein kinase inhibitors

0.00

0.0

2.2

—

Bacterial infection, other or unspecified

0.87

0.00

1.0

1.5

—

Idiopathic gout

0.00

0.0

1.7

—

L04AC Interleukin inhibitors

0.00

0.0

2.2

—

Congenital malformations of cardiac septa

0.00

0.0

2.2

—

Colon adenocarcinoma

0.00

0.0

1.3

—

Other bursopathies

0.00

0.0

1.0

—

0.00

0.0

1.8

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.0

1.4

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.9

—

Generalized epilepsy

0.00

0.0

1.8

—

Normotensive glaucoma

0.00

0.0

1.5

—

Sudden idiopathic hearing loss

0.00

0.0

1.3

—

Necrosis of pulp, including avohilmo

0.98

0.00

1.0

1.5

—

Amputation

0.00

0.0

1.4

—

Chronic suppurative otitis media, including avohilmo

0.00

-0.00

0.0

1.9

—

Viral pneumonia (unknown virus, not influenza)

0.00

-0.00

0.0

2.0

—

Conductive hearing loss, unspecified

0.00

-0.00

0.0

1.3

—

Persistent delusional disorders

0.00

-0.00

0.0

2.2

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

1.9

—

Peripheral artery operations in Hilmo

0.00

-0.00

0.0

1.3

—

Septal defects

0.00

-0.00

0.0

2.2

—

Crossbite

0.00

-0.00

0.0

2.0

—

Acute nasopharyngitis (common cold)

0.00

-0.00

0.0

1.7

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.00

-0.00

0.0

1.3

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

-0.00

0.0

1.2

—

Inguinal or femoral hernia, bilateral

0.00

-0.00

0.0

1.6

—

Bacterial infection, other or unspecified

0.96

-0.00

1.0

1.5

—

Crohn's disease of small intestine

0.00

-0.00

0.0

2.2

—

Other local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

1.3

—

Secondary uncertain malignant neoplasm

0.00

-0.00

0.0

1.3

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

1.4

—

Other inflammatory liver diseases

0.00

-0.00

0.0

2.2

—

Gonarthrosis,primary

0.96

-0.00

1.0

1.5

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

-0.00

0.0

2.0

—

Unspecified abortion

0.00

-0.00

0.0

1.0

—

Prolapse and hernia of ovary and fallopian tube

0.00

-0.00

0.0

1.2

—

Failed induction of labour

0.00

-0.00

0.0

2.6

—

Mixed connective tissue disease

0.00

-0.00

0.0

2.0

—

Nephropathy related operations

0.00

-0.00

0.0

1.8

—

Other eating disorders

0.00

-0.00

0.0

1.0

—

Volume depletion

0.00

-0.00

0.0

1.7

—

Pregnancy with abortive outcome

0.90

-0.00

1.7

1.4

—

Mental and behavioural disorders due to cannabinoids

0.00

-0.00

0.0

1.4

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

-0.00

0.0

2.2

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

4.0

—

Other inflammation of vagina/vulva

0.00

-0.00

0.0

2.0

—

Bacterial pneumonia (organism specified)

0.99

-0.00

1.0

1.5

—

Other obstructive and reflux uropathy

0.00

-0.00

0.0

1.8

—

Otosclerosis

0.00

-0.00

0.0

1.8

—

Inflammatory diseases of the central nervous system

0.00

-0.00

0.0

2.0

—

Heterophoria

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Transverse colon

0.00

-0.00

0.0

1.9

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

2.2

—

conjunctival haemorrhage

0.00

-0.00

0.0

2.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

3.3

—

Polyhydramnios

0.00

-0.00

0.0

4.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.95

-0.00

1.8

1.4

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

3.7

—

Mandibular retrognathia

0.00

-0.00

0.0

1.9

—

Ulcerative proctitis

0.00

-0.00

0.0

2.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

-0.00

0.0

2.2

—

Crowding of teeth, including avohilmo

0.00

-0.00

0.0

1.3

—

Abnormal findings on diagnostic imaging of central nervous system

0.00

-0.00

0.0

2.2

—

Impacted maxillary molar

0.00

-0.00

0.0

1.0

—

Complications of the puerperium, not elsewhere classified

0.00

-0.00

0.0

4.2

—

Bronchitis, not specified as acute or chronic

0.00

-0.00

0.0

2.2

—

Malignant neoplasm of pancreas, including Hilmo

0.00

-0.00

0.0

1.4

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

1.8

—

Collagenous colitis

0.00

-0.00

0.0

1.9

—

Excessive earwax

0.96

-0.00

1.3

1.4

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

0.00

-0.00

0.0

3.5

—

Other ill-defined and unspecified causes of mortality

0.00

-0.00

0.0

1.8

—

Alcoholic liver disease

0.00

-0.00

0.0

2.0

—

Septicaemia

0.99

-0.00

1.0

1.6

—

Explicit bacterial Sepsis

0.00

-0.00

0.0

1.4

—

Chronic suppurative otitis media

0.00

-0.00

0.0

1.7

—

Other obstetric trauma

0.00

-0.00

0.0

3.8

—

Congenital ovarian cysts

0.00

-0.00

0.0

5.0

—

Orchitis and epididymitis

0.00

-0.00

0.0

1.3

—

Disorders of vitreous body

0.93

-0.00

1.2

1.5

—

Gonarthrosis

0.90

-0.00

1.0

1.2

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.8

—

Ill-defined and unknown causes of mortality

0.00

-0.00

0.0

1.8

—

Acute tubulo-interstitial nephritis

0.97

-0.00

1.0

1.5

—

Other disorders of penis

0.00

-0.00

0.0

1.3

—

Dislocation, sprain and strain of joints and ligaments of knee

0.95

-0.00

1.0

1.5

—

Hydronephrosis

0.00

-0.00

0.0

1.7

—

Nonspecific lymphadenitis

0.00

-0.00

0.0

1.4

—

Sicca syndrome [Sjögren]

0.00

-0.00

0.0

1.4

—

Abdominal aortic aneurysm (AAA)

0.00

-0.00

0.0

1.2

—

Inguinal hernia, bilateral

0.00

-0.00

0.0

1.6

—

Other and unspecified injuries of lower leg

0.00

-0.00

0.0

1.9

—

Other otitis externa (chronic)

0.00

-0.00

0.0

1.8

—

Conjunctivitis

0.94

-0.00

1.1

1.4

—

Episcleritis

0.00

-0.00

0.0

2.0

—

Other disorders of cornea

0.00

-0.00

0.0

2.0

—

Erysipelas

0.95

-0.00

1.2

1.5

—

Acute lymphadenitis

0.00

-0.00

0.0

1.4

—

Exposure to other and unspecified inanimate mechanical forces

0.00

-0.00

0.0

1.9

—

Streptococcal septicaemia

0.00

-0.00

0.0

2.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

-0.00

0.0

2.2

—

Fall on and from ladder

0.00

-0.00

0.0

1.8

—

Foreign body or object entering through skin

0.00

-0.00

0.0

1.8

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.3

—

Dislocation, sprain and strain of joints and ligaments of head

0.00

-0.00

0.0

1.8

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

-0.00

0.0

5.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

-0.00

0.0

2.2

—

Contact with other sharp object(s)

0.00

-0.00

0.0

1.8

—

Convalescence

0.00

-0.00

0.0

2.2

—

Other medical care

0.86

-0.00

1.0

1.5

—

Chronic viral hepatitis

0.00

-0.00

0.0

1.8

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS